phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs001584.v1.p1 eMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants | Version 1: passed embargo
| VDAS | 83717 | Case-Control | | Nimblegen Custom SeqCap
|
phs000888.v1.p1 eMERGE Network Imputed GWAS for 41 phenotypes | Version 1: passed embargo
| VDAS | 55029 | Case-Control, Cohort | Links | 1000 Genomes
|
phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000226.v6.p1 STAMPEED: Cardiovascular Health Study (CHS) | Versions 1-6: passed embargo
| VDAS | 4211 | Longitudinal | | HumanOmni1-Quad_v1-0_B HumanCNV370v1
|
phs000287.v6.p1 Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000507.v2.p2 Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans | Versions 1-2: passed embargo
| VDAS | 1200 | Case-Control | Links | |
phs000286.v6.p2 The Jackson Heart Study (JHS) | Versions 1-6: passed embargo
| VDAS | 3889 | Cohort | | HiSeq X Ten
|
phs000850.v1.p1 OPPERA prospective cohort study of first-onset TMJD | Version 1: passed embargo
| VDAS | 3258 | Prospective, Cohort, Longitudinal | Links | Algynomics Pain Research Panel
|
phs000796.v1.p1 Genome Wide Association Study of Chronic TMD: Discovery Phase | Version 1: passed embargo
| VDAS | 3104 | Case-Control | Links | HumanOmni2.5
|
phs000762.v1.p1 OPPERA baseline case-control study of chronic TMJD | Version 1: passed embargo
| VDAS | 1818 | Case-Control | Links | Algynomics Pain Research Panel
|
phs000617.v1.p1 KCNE1Polymorphism as Possible Modulator of Drug-Induced TdP | Version 1: passed embargo
| VDAS | 290 | Case-Control | Links | GoldenGate Assay
|
phs001559.v1.p1 Contribution of Genetic Polymorphisms to the Abuse Liability of Oxycodone | Version 1: passed embargo
| VDAS | 190 | Case Set | Links | Smokescreen Genotyping Array
|
phs001503.v1.p1 Women's Interagency HIV Study (WIHS) | Version 1: passed embargo
| VDAS | 864 | Prospective, Cohort | Links | Smokescreen
|
phs000580.v1.p1 PAGE: CALiCo: Strong Heart Study (SHS) | Version 1:
| VDAS | | Longitudinal Cohort, Longitudinal, Family | Links | TaqMan OpenArrays: CALiCo AOD TaqMan Y1 TaqMan OpenArrays: CALiCo ABD TaqMan Y1 TaqMan OpenArrays: CALiCo DME TaqMan Y1 TaqMan OpenArrays: CALiCo ABD TaqMan Y2 TaqMan OpenArrays: CALiCo AOD TaqMan Y2 TaqMan OpenArrays: CALiCo DME TaqMan Y2 TaqMan OpenArrays: CALiCo Sequenom Y2
|
phs000171.v1.p1 Genetic Multiple Sclerosis Associations - GeneMSA | Version 1: passed embargo
| VDAS | 1920 | Case-Control | Links | HumanHap550v1.1
|